• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sorafenib Induced Hand-Foot Skin Reaction at Low Dose.

作者信息

Shah Vrutika H, Supekar Bhagyashree B, Singh Rajesh P, Mukhi Jayesh I

机构信息

Department of Dermatology, Venereology and Leprosy, Seth G. S. Medical College and K.E.M. Hospital, Parel, Mumbai, India.

Department of Dermatology, Venereology and Leprosy, Government Medical College, Nagpur, Maharashtra, India.

出版信息

Indian Dermatol Online J. 2020 Sep 19;11(6):997-1000. doi: 10.4103/idoj.IDOJ_115_20. eCollection 2020 Nov-Dec.

DOI:10.4103/idoj.IDOJ_115_20
PMID:33344356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7734987/
Abstract
摘要

相似文献

1
Sorafenib Induced Hand-Foot Skin Reaction at Low Dose.低剂量索拉非尼诱发的手足皮肤反应
Indian Dermatol Online J. 2020 Sep 19;11(6):997-1000. doi: 10.4103/idoj.IDOJ_115_20. eCollection 2020 Nov-Dec.
2
Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib.手足皮肤反应与索拉非尼治疗转移性肾细胞癌患者的临床结局相关。
Jpn J Clin Oncol. 2013 Oct;43(10):1023-9. doi: 10.1093/jjco/hyt110. Epub 2013 Aug 15.
3
Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.索拉非尼治疗患者的手足皮肤反应：多靶点激酶抑制剂治疗所致皮肤表现的临床病理研究
Br J Dermatol. 2008 Mar;158(3):592-6. doi: 10.1111/j.1365-2133.2007.08357.x. Epub 2007 Dec 6.
4
Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study.尿素乳膏对肝细胞癌患者索拉非尼相关手足皮肤反应的影响：一项多中心、随机、双盲对照研究。
Eur J Cancer. 2020 Nov;140:19-27. doi: 10.1016/j.ejca.2020.09.012. Epub 2020 Oct 8.
5
Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.索拉非尼引起手足皮肤反应的风险：一项系统评价和荟萃分析。
Acta Oncol. 2008;47(2):176-86. doi: 10.1080/02841860701765675.
6
Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.索拉非尼相关手足皮肤反应：诊断、机制、预防和管理的实用建议。
Expert Rev Clin Pharmacol. 2019 Dec;12(12):1121-1127. doi: 10.1080/17512433.2019.1689122. Epub 2019 Nov 8.
7
Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients.索拉非尼治疗晚期肝细胞癌患者的累积剂量增加和手足皮肤反应出现延长无进展生存期。
Kaohsiung J Med Sci. 2018 Jul;34(7):391-399. doi: 10.1016/j.kjms.2018.03.006. Epub 2018 Apr 4.
8
Severe hand-foot skin reaction and erythema multiforme-like lesions due to sorafenib.索拉非尼引起的严重手足皮肤反应和多形红斑样病变。
Postgrad Med J. 2018 Sep;94(1115):535-536. doi: 10.1136/postgradmedj-2018-136027. Epub 2018 Sep 17.
9
Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib.多激酶抑制剂相关手足皮肤反应可预测索拉非尼治疗肝细胞癌患者的结局。
World J Gastroenterol. 2018 Jul 28;24(28):3155-3162. doi: 10.3748/wjg.v24.i28.3155.
10
Hand-foot-skin reaction related to use of the multikinase inhibitor sorafenib and hard orthotics.与使用多激酶抑制剂索拉非尼及硬支具相关的手足皮肤反应
Pediatr Dermatol. 2018 Jul;35(4):e206-e209. doi: 10.1111/pde.13523. Epub 2018 May 15.

本文引用的文献

1
Effective prevention of sorafenib-induced hand-foot syndrome by dried-bonito broth.用柴鱼高汤有效预防索拉非尼引起的手足综合征。
Cancer Manag Res. 2018 Apr 17;10:805-813. doi: 10.2147/CMAR.S159370. eCollection 2018.
2
Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol.外用骨化三醇治疗索拉非尼相关的手足综合征。
JAAD Case Rep. 2017 Jul 20;3(4):354-357. doi: 10.1016/j.jdcr.2017.03.017. eCollection 2017 Jul.
3
Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: report of a case and literature review of kinase inhibitors and blocking antibodies.
舒尼替尼引起的手足皮肤反应和毛发色素脱失并存：1例报告及激酶抑制剂和阻断抗体的文献综述
Indian J Dermatol. 2014 Nov;59(6):588-91. doi: 10.4103/0019-5154.143525.
4
Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma.索拉非尼诱发的肾细胞癌患者手足综合征。
Indian J Pharmacol. 2014 May-Jun;46(3):334-6. doi: 10.4103/0253-7613.132189.
5
Drug therapy: sorafenib.药物治疗：索拉非尼。
Hepatology. 2010 May;51(5):1843-9. doi: 10.1002/hep.23676.
6
Skin toxicities of targeted therapies.靶向治疗的皮肤毒性。
Eur J Cancer. 2009 Sep;45 Suppl 1:295-308. doi: 10.1016/S0959-8049(09)70044-9.
7
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.接受多靶点激酶抑制剂索拉非尼和舒尼替尼治疗的患者的皮肤不良反应。
Br J Dermatol. 2009 Nov;161(5):1045-51. doi: 10.1111/j.1365-2133.2009.09290.x. Epub 2009 May 5.
8
Dermatologic symptoms associated with the multikinase inhibitor sorafenib.与多激酶抑制剂索拉非尼相关的皮肤症状。
J Am Acad Dermatol. 2009 Feb;60(2):299-305. doi: 10.1016/j.jaad.2008.06.034. Epub 2008 Nov 25.
9
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.与多靶点激酶抑制剂索拉非尼和舒尼替尼相关的手足皮肤反应的管理策略进展
Oncologist. 2008 Sep;13(9):1001-11. doi: 10.1634/theoncologist.2008-0131. Epub 2008 Sep 8.
10
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.新型多激酶抑制剂索拉非尼皮肤不良反应的前瞻性研究。
Arch Dermatol. 2008 Jul;144(7):886-92. doi: 10.1001/archderm.144.7.886.